A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia
NCT01852682 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2014-11-13
Summary
The purpose of this study is to investigate efficacy and safety, when administering PA21, in peritoneal dialysis patients having hyperphosphatemia.
Conditions
- Peritoneal Dialysis
- Hyperphosphatemia
Interventions
- DRUG
-
PA21
Sponsors & Collaborators
-
Kissei Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2014-03-31
Countries
- Japan
More Related Trials
-
A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
NCT06745531 ·Status: COMPLETED ·Phase: PHASE3
-
Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
NCT04766398 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
NCT04767581 ·Status: COMPLETED ·Phase: PHASE3
-
Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
NCT04771780 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
NCT07285304 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
NCT06745518 ·Status: COMPLETED ·Phase: PHASE2
-
Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients
NCT03864445 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
NCT01017276 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis
NCT04766385 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients
NCT01324128 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-finding Study of KHK7791 in Hyperphosphatemia Patients
NCT03864458 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
NCT00506441 ·Status: COMPLETED ·Phase: PHASE3
-
A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD
NCT03831607 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Finding Study to Treat High Phosphate Levels in the Blood.
NCT02081534 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
NCT01464190 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
NCT02151643 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
NCT05699239 ·Status: COMPLETED ·Phase: PHASE2
-
AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia
NCT07030595 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
NCT00542815 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
NCT01742611 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Reducing Phosphorus Absorption on Cardiac Biomarkers in Hemodialysis Patients
NCT01781156 ·Status: UNKNOWN
-
Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
NCT00772382 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
NCT06712654 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
PA21 Safety and Efficacy in Adult Chinese Subjects
NCT03644264 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate
NCT01514851 ·Status: COMPLETED ·Phase: PHASE3